logo
Plus   Neg
Share
Email

Gilead To Present New Data From Its HIV Research & Development Program - Quick Facts

Gilead Sciences, Inc. (GILD) announced that new data from the company's HIV research and development program will be presented at the 23rd International AIDS Conference. Phase 1 trial results supporting further evaluation of a six-month dosing interval for a sustained delivery formulation of Gilead's investigational HIV-1 capsid inhibitor, lenacapavir (GS-6207), will be presented at the Conference.

The company said the HIV treatment data to be presented includes a pooled analysis of four international trials evaluating the safety and efficacy of Biktarvy in adults aged 65 or older.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Former Google engineer Anthony Levandowski was sentenced by a U.S. judge to eighteen months in prison for stealing trade secrets from Google's self-driving car unit before he defected to Uber's rival unit. Levandowski admitted that from 2009 to 2016, he worked in Google's self-driving car program, known then as Project Chauffer. JetBlue has strengthened its face covering policy, by prohibiting face masks with vents or exhalation valves, starting August 10. It will also no longer allow customers to claim exemptions from wearing a face covering altogether. Home Depot, Inc. is set to open three new distribution centers in Georgia over the next 18 months, which is expected to create an additional 1,000 new jobs in Greater Atlanta, including full-time and part-time positions. The home improvement retailer has already created more than 5,000 new jobs in Georgia over the last five years.
Follow RTT